Article
Massimo Di Maio, Francesco Perrone, Pierfranco Conte
Season 1, Episode 9: Career Insights From a CEO with Mark Erlander
We are thrilled to welcome Mark Erlander PHD, CEO of Cardiff Oncology, shares his journey from a PhD in neuroscience to leading an oncology company. He discusses the calculated risks he took throughout his career and the importance of following your passion. Erlander emphasizes the need for leaders to be motivated and to create a team that is excited to work together. "Create a motivated team by fostering trust, respect, and providing resources" He tells up and comers to do something they are truly excited about, but also be be opportunistic and willing to take calculated risks. We jump in to discussions on the future of cancer treatments, including targeted therapies and personalized medicine.
Key Points:
❇Follow your passion and do something you are truly excited about
🤗Create a motivated team by fostering trust, respect, and providing resources
📈Be opportunistic and willing to take calculated risks
❌Never settle for something that is less than what you want to achieve
💊The future of cancer treatments includes targeted therapies and personalized medicine
Related Topics
You May Also Like
Massimo Di Maio, Francesco Perrone, Pierfranco Conte
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Thakur, Sayanta & Lahiry, Sandeep
Accelerated drug approvals in oncology: Pros and cons
Article
Haiqing Isaac Dai, Yulia Vugmeyster, Naveen Mangal
Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects
Article
Laleh Amiri-Kordestani & Richard Pazdur
Oncology approvals in 2020: a year of firsts in the midst of a pandemic
Article
Sean X Zhang, MSc , Dean Fergusson, PhD , Jonathan Kimmelman, PhD